Family Study in Schizophrenia

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2008 by Sheba Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00418912
First received: January 4, 2007
Last updated: February 13, 2008
Last verified: February 2008
  Purpose

Schizophrenia is a severe mental illness which is considered to have, among other, a genetic etiology. One of the most efficient tools in genetic-psychiatry is the investigation of multiplex families.

The current study will identify patients of multiplex families and to map their family connections and the presence of mental illnesses among family members.


Condition
Schizophrenia
Family
Genetics

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Prospective

Resource links provided by NLM:


Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 100
Study Start Date: March 2007
Estimated Study Completion Date: January 2009
Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

schizophrenia

Criteria

Inclusion Criteria:

  1. Schizophrenia
  2. Multiplex family
  3. Able to understand and sign the informed concent form.
  4. Hebrew speaker
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00418912

Contacts
Contact: Raz Gross, MD 972-3-5303962 razg@gertner.health.gov.il
Contact: Michael Bunzel, MD 972-3-530

Locations
Israel
Psychiatric unit, Sheba Medical Center Recruiting
Tel Hashomer, Israel, 52621
Contact: Michael Bunzel, MD       chiba2@actcom.net.il   
Principal Investigator: Michael Bunzel, MD         
Seba Medical Center Recruiting
Tel Hashomer, Israel
Contact: Michael Bunzel, MD         
Principal Investigator: Michaael Bunzel, MD         
Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Raz Gross, MD Mental Health Epidemiology & Psychosocial Aspects of Illness, The Gertner Institute for Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer , Israel
Study Director: Michael Bunzel, MD Psychiatric Unit, Sheba Medical Center, Tel Hashomer, Israel
  More Information

No publications provided

Responsible Party: Raz Gross, Head, Mental Health Epidemiology, The Gertner Institute for Epidemiology
ClinicalTrials.gov Identifier: NCT00418912     History of Changes
Other Study ID Numbers: SHEBA-06-4329-RG-CTIL
Study First Received: January 4, 2007
Last Updated: February 13, 2008
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders

ClinicalTrials.gov processed this record on August 01, 2014